-Previously, ␤-thalassemia, an inherited anemic disorder with iron overload caused by loss-of-function mutation of ␤-globin gene, has been reported to induce osteopenia and impaired whole body calcium metabolism, but the pathogenesis of aberrant calcium homeostasis remains elusive. Herein, we investigated how ␤-thalassemia impaired intestinal calcium absorption and whether it could be restored by administration of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] or hepcidin, the latter of which was the liver-derived antagonist of intestinal iron absorption. The results showed that, in hemizygous ␤-globin knockout (BKO) mice, the duodenal calcium transport was lower than that in wild-type littermates, and severity was especially pronounced in female mice. Both active and passive duodenal calcium fluxes in BKO mice were found to be less than those in normal mice. This impaired calcium transport could be restored by 7-day 1,25(OH)2D3 treatment. The 1,25(OH)2D3-induced calcium transport was diminished by inhibitors of calcium transporters, e.g., L-type calcium channel, NCX1, and PMCA1b, as well as vesicular transport inhibitors. Interestingly, the duodenal calcium transport exhibited an inverse correlation with transepithelial iron transport, which was markedly enhanced in thalassemic mice. Thus, 3-day subcutaneous hepcidin injection and acute direct hepcidin exposure in the Ussing chamber were capable of restoring the thalassemia-associated impairment of calcium transport; however, the positive effect of hepcidin on calcium transport was completely blocked by proteasome inhibitors MG132 and bortezomib. In conclusion, both 1,25(OH)2D3 and hepcidin could be used to alleviate the ␤-thalassemia-associated impairment of calcium absorption. Therefore, our study has shed light on the development of a treatment strategy to rescue calcium dysregulation in ␤-thalassemia.
hemizygous ␤-globin knockout (BKO) mice had widespread osteopenia and severe impairment of intestinal calcium absorption, the latter of which could not be restored by conventional administration of 1,25-dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ] (5, 41). Since the intestinal calcium absorption is composed of many transport components, it is not known which component (i.e., transcellular or paracellular component) is impaired in ␤-thalassemia.
Under normal conditions, calcium is absorbed across the leaky small intestine by both transcellular and paracellular pathways (4) . The duodenum, being the proximal part of the small intestine, which is normally exposed to a large amount of ionized calcium released in this relatively acidic environment, is the site with the highest calcium absorption rate (20) . Regarding the transcellular pathway, calcium traverses the apical membrane through a number of calcium channels, e.g., transient receptor potential cation channels, vanilloid subfamily (TRPV) 5 and 6, and L-type calcium channels (e.g., Ca v 1.3), followed by calbindin-D 9k -mediated cytoplasmic calcium translocation and basolateral calcium efflux via Na ϩ / Ca 2ϩ exchanger (NCX)-1 and plasma membrane Ca 2ϩ -ATPase (PMCA 1b ). Meanwhile, some cytosolic calcium may be transported in lysosome-like vesicles prior to exocytosis, a mechanism known as vesicular calcium transport (45) . Besides the transcellular pathway, there is the paracellular calcium transport that is dependent on luminal calcium concentration, i.e., the higher the luminal concentration, the greater the paracellular calcium flux (19) . In rodents, both mechanisms of calcium transport are markedly stimulated by 3-day subcutaneous injection of 1,25(OH) 2 D 3 (22, 23) . This is because the functions of most calcium transporters, particularly TRPV6, NCX1, and PMCA 1b , are 1,25(OH) 2 D 3 dependent (46) . Thus, it has long been hypothesized that 1,25(OH) 2 D 3 administration is able to mitigate the thalassemia-induced impairment of intestinal calcium transport.
Indeed, the exact cause of impaired calcium absorption in ␤-thalassemia is not completely understood. Since the intestinal iron absorption usually shows inverse correlation with calcium absorption, it is possible that a decrease in calcium transport in ␤-thalassemia is secondary to excessive iron transport, which is often observed in this disease (2) . Several factors contribute to the thalassemia-induced iron hyperabsorption, for example, a lower than normal level of hepcidin, which is a liver-derived negative regulator of intestinal iron absorption (9) . Hepcidin, a 25-amino acid peptide hormone, targets the basolateral iron transporter ferroportin 1 (FPN1; known as hepcidin receptor), leading to proteolytic degradation of the apical divalent metal transporter (DMT) 1 and/or FPN1 in various epithelial cells, including intestinal enterocytes and kidney cells (3, 33) . Thus we postulated that hepcidin administration should be able to alleviate the thalassemia-induced impairment of calcium transport.
The objectives of the present study were to 1) find out whether transcellular or paracellular duodenal calcium transport or both were impaired in BKO mice and 2) investigate whether 1,25(OH) 2 D 3 and hepcidin administration could restore the duodenal calcium transport. The duodenal segment was used in this study because it normally has both transcellular and paracellular calcium transport as well as hepcidindependent iron uptake (16, 20, 36) .
MATERIALS AND METHODS

Animals
Male and female hemizygous ␤-globin knockout (␤ ϩ/th3 ; BKO) thalassemic mice and their wild-type C57BL/6 littermates (8 wk old, weighing 15-30 g) were obtained from the Thalassemia Research Center, Institute of Molecular Biosciences (Mahidol University, Nakhom Pathom, Thailand). All BKO mice exhibited a phenotype of ␤-thalassemic intermedia (24) . The genotype was verified by DNA analysis, as described previously (18) . Mice were housed in the husbandry unit (polystyrene shoebox cages) with room temperature of ϳ25°C and humidity of 50 -60% under a 12:12-h dark-light cycle (lights on at 0600; average illuminance of 150 -200 lux in the day time). They were fed regular chow containing 0.9% wt/wt phosphorus, 1.0% wt/wt calcium, and 4,000 IU/kg vitamin D (CP, Bangkok, Thailand) and reverse-osmosis (RO) water ad libitum. Body weights were recorded before sample collections. Animals were divided into each experimental group in a random fashion. Before sample collections, mice were anesthetized by intraperitoneal injection of 70 mg/kg sodium pentobarbitone (Ceva Santé Animale, Libourne, France). This study was approved by the Institutional Animal Care and Use Committee of the Faculty of Science, Mahidol University.
Experimental Design Experiment 1. To determine dose-and time-dependent responses of 1,25(OH) 2D3-stimulated calcium absorption, BKO and age-matched wild-type (WT) mice were injected daily [subcutaneous (sc) injection] with 1 or 2 g/kg 1,25(OH) 2D3 (catalog no. 71820; Cayman Chemical, Ann Arbor, MI) for 3 days, 0.5 g/kg 1,25(OH)2D3 for 7 days, or 3 ml/kg 9:1 propylene glycol-ethanol (vehicle) as control. The duodenal tissues were collected for transepithelial calcium flux measurement by using the Ussing chamber technique. The effective time and dose of 1,25(OH) 2D3-stimulated calcium absorption was used in the following experiments. Before euthanasia, a median thoracotomy was performed, and arterial blood (200 -500 l) was collected by cardiac puncture for measurement of testosterone (only male mice), progesterone, and 17␤-estradiol. In some experiments, BKO mice were injected with 17␤-estradiol (2.5 g/kg sc once daily for 3 days; Sigma) or vehicle (5 ml/kg sc corn oil once daily) to determine whether an estrogen supplement was able to restore duodenal calcium transport. This conventional regimen of estrogen supplementation was previously reported to completely reverse the adverse effects of bilateral ovariectomy (38 Experiment 3. This study aimed to investigate whether hepcidin was able to restore the impaired transcellular calcium transport in thalassemic mice. The experimental design was shown in Fig. 5A . Female BKO mice were injected daily with 100 g/kg sc hepcidin (catalog no. 4434-s; Peptide Institute, Osaka, Japan) for 3 days, followed by study of duodenal calcium transport by Ussing chamber 4 or 24 h after the last hepcidin injection. The acute effect of single-dose hepcidin injection on calcium transport 4 h later was also evaluated. Furthermore, to determine the direct action of hepcidin, duodenal tissue was exposed for 30 min to bathing solution containing 200 nM hepcidin in the Ussing chamber before calcium flux measurement. In addition, the cellular mechanism of hepcidin was also determined. In some experiments, the duodenal tissues were incubated with proteasome inhibitors, i.e., 10, 20, or 50 mM MG132 (catalog no. C2211; Sigma) or 10, 50, or 100 M bortezomib (catalog no. S1013; Selloeck Chemical), during tissue equilibration to abolish the hepcidin effect. Thereafter, a proteasome inhibitor was also in the chamber throughout the flux measurement.
Ussing Chamber Study of Transepithelial Ion Fluxes
Tissue preparation. After a 1.5-cm median laparotomy, duodenal tissue (0 -5 cm from the pylorus) was removed and cut longitudinally to expose the mucosa. Since we observed previously that the muscle layers of the duodenums did not affect calcium flux measurement (6), they were not stripped of the muscle layers. Thereafter, the duodenal tissue was mounted immediately in an Ussing chamber with an exposure area of 0.3 cm 2 . Bathing solution contained (in mM) 118 NaCl, 4.7 KCl, 1.25 CaCl2, 1.1 MgCl2, 23 NaHCO3, 12 D-glucose, and 2 mannitol (all purchased from Sigma) and was maintained at 37°C and osmolality of ϳ290 mmol/kg H 2O. Each hemichamber was aerated with 5% CO2 in 95% O2.
Calcium flux measurement. Transepithelial calcium fluxes were determined as described previously (19, 22) . Briefly, the tissue was first equilibrated in the chamber with physiological bathing solution for 10 min. In some experiments, duodenal tissue was preincubated with inhibitor(s) for 10 min during tissue equilibration or preincubated with hepcidin for 30 min. Thereafter, the equilibrating solution was discarded and the basolateral chamber filled with fresh bathing solution, while the apical chamber was refilled with bathing solution containing radioactive 45 Ca (0.45 Ci/ml, final specific activity of 360 mCi/mol, catalog no. NEZ013; Perkin-Elmer, Boston, MA). Unidirectional calcium flux (J H ¡ C; nmol·h Ϫ1 ·cm Ϫ2 ) from the hot side (H; apical side) to the cold side (C; basolateral side) was calculated using Eqs. 1 and 2:
where R H ¡ C is the rate of tracer appearance in the cold side (counts·min Ϫ1 ·h Ϫ1 ), SH is the specific activity in the hot side (counts·min Ϫ1 ·nmol Ϫ1 ), A is the surface area of the tissue (cm 2 ), CH is the mean radioactivity in the hot side (counts/min), and CTo is the total calcium content in the hot side (nmol).
Radioactivity of 45 Ca was analyzed by la iquid scintillation spectrophotometer (model Tri-Carb 3100; Packard, Meriden, CT). Total calcium concentration in the bathing solution was analyzed by an atomic absorption spectrometer (model SpectrAA-300; Varian Techtron). In the absence of transepithelial calcium gradient, i.e., calcium concentration in both apical and basolateral hemichambers was 1.25 mM, the measured calcium flux represented the active calcium transport. To determine the paracellular passive calcium transport, the apical hemichamber contained various calcium concentrations of 10, 20, and 40 mM (5 mice/concentration), whereas the basolateral hemichamber contained 1.25 mM calcium. In the present study, the transepithelial flux means the mucosa-to-serosa (apical-to-basolateral) unidirectional flux. The serosa-to-mucosa flux across the duodenal epithelium is very small and can be considered negligible compared with the enhanced mucosa-to-serosa flux (6) .
Iron and zinc flux measurement. The tissue was first equilibrated in the chamber with physiological bathing solution; thereafter, the mucosal chamber was filled with bathing solution containing radioactive 59 Fe (0.2 Ci/ml, final specific activity of 5 ϫ 10 11 mCi/mol, catalog no. NEZ037001; Perkin-Elmer) or 65 Zn (0.7 Ci/ml, final specific activity of 5 ϫ 10 12 mCi/mol, catalog no. NEZ111001; PerkinElmer). In the absence of transepithelial iron gradient (i.e., bathing solution in both hemichambers contained the same iron or zinc concentration of 20 M), the measured transepithelial flux represented the active iron or zinc transport, which was also calculated by using Eqs. 1 and 2.
The pH level of the mucosal solution was kept constant at 7.4 by CO 2-HCO3 Ϫ buffer system. Although mucosal acidic pH can enhance iron absorption, acute exposure to acidic pH markedly reduces calcium absorption (7) . Moreover, the duodenal mucosal cells abundantly express the duodenal cytochrome B (Dcytb), which is a reductase for conversion of Fe 3ϩ to Fe 2ϩ . Therefore, the duodenum should be able to transport iron without reduction in pH of the mucosal solution.
Epithelial electrical measurement. Two epithelial electrical parameters, i.e., transepithelial potential difference (PD) and short-circuit current (Isc), were obtained by Ag/AgCl half-cell connected to each hemichamber through a salt bridge (4 M KCl in 4 g wt/vol agar), as described previously (19) . Two PD-sensing Ag/AgCl electrodes were placed adjacent to the mounted duodenal tissue and were connected to a preamplifier (model EVC-4000; World Precision Instruments, Sarasota, FL) and finally to a PowerLab/4SP (AD Instruments, Colorado Springs, CO). The current-applying Ag/AgCl electrodes were placed at the distant end of each hemichamber to supply Isc, which was also measured by the EVC-4000/PowerLab system. Transepithelial resistance (TER) was calculated from PD and Isc by Ohm's equation.
Western Blot Analysis
As for total protein extraction, the duodenum (ϳ2-3 cm) was cut longitudinally and cleaned twice in ice-cold normal saline. The mucosal cells were scraped with a glass slide. Cell lysate was prepared by using the RIPA Lysis Buffer System (catalog no. sc-24948; Santa Cruz Biotechnology, Santa Cruz, CA). Protein samples were then subjected to 10% SDS-PAGE and transferred onto nitrocellulose membranes. Thereafter, membranes were incubated with rabbit polyclonal anti-FPN1 antibody (1/1,000, catalog no. ab85370; Abcam), mouse monoclonal anti-DMT1 antibody (1/500, catalog no. ab55812; Abcam), or anti-␤-actin antibody (1/2,000, catalog no. sc-47778; Santa Cruz Biotechnology) at 4°C overnight. This anti-DMT1 antibody has been used to detect DMT1 in the mouse brain by Bartelle et al. (1) , whereas the anti-FPN1 antibody has been used previously by Scheers et al. (37) . After washing, membranes were incubated with 1/2,000 goat anti-mouse or 1/1,000 goat anti-rabbit secondary antibody (sc-2005 or sc-2004, respectively; Santa Cruz Biotechnology) at 25°C for 2 h. Protein bands were detected by using an enhanced chemiluminescence kit (Merck Millipore, Billerica, MA) and visualized under the FluorChem SP 4.1 system (Alpha Innotech, San Leandro, CA).
Hormone Assays
Progesterone and testosterone levels were measured by automated chemiluminescent immunoassay (Immulite 2000 XPi Immunoassay System; Siemens, Erlangen, Germany). The levels of 17␤-estradiol were determined by chemiluminescent immunoassay using Cobas 6000 analyzer with e601 modules (Roche, Rotkreuz, Switzerland). Mouse 1,25(OH) 2D3 levels were measured by double-sandwich enzyme-linked immunosorbent assay kit (catalog no. MBS726551, inter-and intra-assay coefficient of variation Ͻ10%; MyBioSource).
Statistical Analysis
Data are expressed as means Ϯ SE. Two sets of data with nonnormal distribution were compared by Mann-Whitney test, whereas one-way analysis of variance (ANOVA) followed by Dunnett's test was used for multiple sets of data. Two-way ANOVA was used to determine the significant level when evaluating the effect of sexes and genotypes on transepithelial calcium flux. Linear regression was used to determine the correlation between calcium and iron fluxes. The level of significance for all statistical tests was P Ͻ 0.05. All data were analyzed by GraphPad Prism 6.0 for Mac OS X (GraphPad Software, San Diego, CA).
RESULTS
␤-Thalassemia Was Associated With Decreases in Ovarian Hormones
Blood smear of ␤-globin knockout mice exhibited severe microcytic anemia with anisocytosis and poikilocytosis (Fig.  1A) , consistent with blood picture of thalassemia intermedia. Blood counts showing decreases in hemoglobin and hematocrit levels ( Table 1) confirmed anemia in thalassemic mice. Since ␤-thalassemia in humans has been reported to result in impairment of multiple endocrine systems due to iron deposition in endocrine tissues, we determined the circulating levels of sex hormones in BKO mice. As shown in Fig. 1 , B-E, the levels of 17␤-estradiol and progesterone were lower in female BKO mice than in WT mice, whereas testosterone levels in male BKO mice were the same as in WT mice. Serum 1,25(OH) 2 D 3 levels in female BKO mice were lower compared with WT females. A conventional regimen of estrogen supplementation did not alter the duodenal calcium transport in female BKO mice (Fig. 1F) .
Both Active and Passive Calcium Absorption Were Impaired in BKO Mice
In the absence of transepithelial calcium gradient, the duodenal calcium transport in both male and female BKO mice was markedly reduced compared with WT mice, suggesting that thalassemia caused impairment of the active calcium absorption. Interestingly, two-way ANOVA indicated that the thalassemia-induced impairment of duodenal active calcium transport was sex dependent (Table 2) . Specifically, although the duodenal calcium transport in female WT mice was significantly greater than that in male mice, calcium transport was diminished to the same level in ␤-thalassemia (Table 2) . Since the decrease in calcium transport was apparently more severe in female BKO mice, female mice were used in the subsequent study. In addition, the paracellular passive calcium transport of BKO mice was also less than that of the WT mice (Fig. 2B) http://ajpendo.physiology.org/ mice (13). However, this conventional regimen was apparently ineffective (Fig. 2A) . Interestingly, we found that the duodenal active calcium transport in BKO mice was successfully rescued by a longer treatment (7 days) with a lower dose of 1,25(OH) 2 D 3 , i.e., 0.5 g/kg once daily ( Fig. 2A) (Fig. 3B) . Since L-type calcium channel was also essential for the basolateral exocytosis of calcium, nifedipine was also added into the basolateral bathing solution, which was found to diminish the 1,25(OH) 2 D 3 -enhanced duodenal active calcium transport.
The Transepithelial Iron Absorption Showed an Inverse Correlation With Calcium Transport
BKO mice were found to have greater transepithelial iron transport than WT mice (Fig. 4A) , but the serum levels of free iron appeared to be similar (Fig. 4B) . This iron hyperabsorption in BKO mice was completely abolished by 100 g/kg hepcidin administration, consistent with a decrease in serum iron levels (Fig. 4, A and B) . A correlation analysis showed that the duodenal calcium transport was inversely correlated with the Values are means Ϯ SE. WT, wild-type; BKO, ␤-globin knockout thalassemic; RBC, red blood cell count; Hb, hemoglobin concentration; Hct, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; RDW, red cell distribution width (variation in red blood cell size or volume). Blood samples were obtained from 11-wk-old male mice. *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001, BKO vs. WT. Values are means Ϯ SE, Psex, 2-way ANOVA, significant level for differences between sexes for transepithelial calcium flux; Pgenotype, 2-way ANOVA, significant level for differences between genotypes for transepithelial calcium flux; Psexϫgenotype, 2-way ANOVA, significant level for differences between the interaction of sex and genotype for transepithelial calcium flux. P Ͻ 0.05 is considered significant. duodenal iron transport (Fig. 4C) . Nevertheless, in the presence of apical Zn 2ϩ concentration of 20 M, ␤-thalassemia did not affect the transepithelial transport of zinc (Fig. 4D) .
Hepcidin Potently Rescued the Thalassemia-Associated Impairment of Transcellular Calcium Transport
As an antagonist of intestinal iron absorption, hepcidin was expected to rescue calcium transport in thalassemic mice. However, hepcidin had a relatively short half-life (13) . To demonstrate whether it could produce a long-lasting positive effect on calcium transport, hepcidin was administered subcutaneously for 3 days, as depicted in Fig. 5A . With this regimen, hepcidin injection had no effect on the transcellular calcium transport in WT mice (Fig. 5B) . On the other hand, 100 g/kg hepcidin, followed by a 4-h but not 24-h interval prior to Ussing chamber study, effectively restored duodenal calcium transport in BKO mice (Fig. 5B) . Moreover, a single-dose hepcidin injection followed by a 4-h interval and direct exposure to 200 nM hepcidin in Ussing chamber also rescued the impaired transcellular calcium transport in BKO mice. The data suggested that hepcidin action on calcium absorption in BKO mice was acute and transient. Unlike the effects of 1,25(OH) 2 D 3 , hepcidin did not alter the epithelial electrical parameters ( Table 4 ), indicating that hepcidin affected neither epithelial permeability nor integrity.
The Positive Effect of Hepcidin on Iron and Calcium Transport in BKO Mice Could Be Abolished by Proteasome Inhibitors
Thalassemic mice exhibited an increase in the duodenal expression of DMT1 (Fig. 6A ). This upregulated DMT1 protein expression was apparently abolished by 100 g/kg hepcidin injection (Fig. 6B) , which has been reported to result from proteasomal degradation of DMT1 (3). Nevertheless, duodenal FPN1 expression in BKO mice was not changed even by the effect of hepcidin (Fig. 6, A and C) . The present study in BKO mice also indicated that the hepcidin-induced suppression of duodenal iron transport was abolished by proteasome inhibitors 50 mM MG132 and 100 M bortezomib (Fig. 6D) . Moreover, the hepcidin-enhanced calcium transport was also inhibited by proteasome inhibition (Fig. 6E) .
DISCUSSION
Dysregulation of calcium metabolism was one of the most important metabolic disturbances in ␤-thalassemia, leading to osteopenia, osteoporosis, and fracture in humans and rodents (41, 43) . In an attempt to explore the cause of osteopenia in thalassemia, we demonstrated herein that both transcellular and paracellular calcium fluxes in the duodenum of BKO mice were much reduced compared with those in the WT littermate. Although normal female mice exhibited greater duodenal active calcium transport consistent with that reported previously (40) , presumably because of the stimulatory effect of estrogen on calcium absorption (8), this sex difference was not observed in thalassemic mice. Indeed, in female BKO mice, the thalassemia-associated impairment of calcium absorption could not be explained simply by decreases in the secretion of ovarian hormones since the plasma levels of estrogen were slightly reduced and progesterone, despite a substantial decrease in circulating level, reportedly had no significant effect on intestinal calcium transport (26, 39) . Consistently, estrogen supplement could not alleviate the thalassemia-associated impairment of calcium transport (Fig. 1F ). An investigation in thalassemic patients further suggested that the abnormal circulating vitamin D levels were sex independent (14) . Moreover, our previous study using quantitative real-time PCR did not show differences in the expression of key vitamin D-dependent calcium transporter genes, i.e., TRPV5, TRPV6, calbindin-D 9k , and Values are means Ϯ SE; n ϭ 5 males and 7 females in each group. 1,25(OH)2D3, 1,25-dihydroxyvitamin D3; PD, transepithelial potential difference; Isc, short circuit current; TER, transepithelial resistance. *P Ͻ 0.05 and **P Ͻ 0.01 compared with corresponding vehicle-treated WT group; #P Ͻ 0.05 compared with corresponding vehicle-treated BKO group. Vehicletreated mice were injected with 3 ml/kg sc 9:1 propylene glycol-ethanol, and 1,25(OH)2D3-treated mice were injected with 0.5 g/kg sc 1,25(OH)2D3 for 7 days prior to electrical parameter measurement. †Values are the magnitudes of PD, and the apical side is negative with reference to the basolateral side.
PMCA 1b , or nuclear vitamin D receptor (VDR) in thalassemic mice (5) . Therefore, it might be the iron hyperabsorption that hindered duodenal calcium transport in BKO mice, which as shown here could be completely restored by 1,25(OH) 2 D 3 and hepcidin administration.
Of particular interest was to find out the effective doses and regimen of 1,25(OH) 2 D 3 treatment to restore calcium transport in BKO mice. In WT mice, the duodenum was well responsive to 3-day injection of 1 or 2 g/kg 1,25(OH) 2 D 3 , which were the conventional 1,25(OH) 2 D 3 regimens for stimulation of the active calcium absorption (22) . However, despite no change in VDR expression (5), the duodenal calcium transport in BKO mice did not respond to the conventional 1,25(OH) 2 D 3 regimen. On the other hand, they required longer duration of 1,25(OH) 2 D 3 treatment (7 days), but the dose was not necessarily as high as 1 g/kg body wt. Although the dosage of 1,25(OH) 2 D 3 may be further reduced by using 1,25(OH) 2 D 3 -hepcidin combined treatment, the patients are more likely to be compliant with monotherapy rather than multiple-drug therapy. Thus, we evaluated only the efficacy of 1,25(OH) 2 D 3 or hepcidin monotherapy in the present study.
Both transcellular and paracellular calcium transport were restored by this 7-day 1,25(OH) 2 D 3 treatment. In general, the transepithelial calcium transport in the absence of calcium concentration gradient (e.g., Fig. 2A) consists of the transcellular active calcium transport and another convective component known as the solvent drag-induced calcium transport, in which calcium traversed the paracellular space along with the convective water flow in a vitamin D-dependent manner (46) . Therefore, a number of inhibitors of the transcellular calcium transporters were employed to confirm that the observed 1,25(OH) 2 D 3 -induced calcium flux really occurred through the transcellular pathway. As depicted in Fig. 3 , blockade of the principal calcium transporters, i.e., NCX1 (KB-R7943) and PMCA 1b (TFP and vanadate), in the basolateral membrane completely abolished the 1,25(OH) 2 D 3 -induced calcium flux, confirming that it was the transcellular calcium transport that was stimulated by 1,25(OH) 2 D 3 . Nevertheless, how inhibition of either NCX1 or PMCA 1b (or even vesicular calcium transport) led to a complete inhibition of calcium transport remains elusive. It is probable that a restriction of basolateral calcium efflux may trigger a feedback mechanism to close the apical A B Fig. 3 . Transepithelial calcium fluxes in the duodenums of female ␤-globin knockout (BKO) and wild-type (WT) mice after 7 days of daily 0.5 g/kg 1,25(OH)2D3 injection. The duodenal tissue was incubated with apical calcium transport inhibitors, i.e., nifedipine and isradipine (A), or basolateral calcium transport inhibitors, i.e., KB-R7943, TFP, or vanadate, or the vesicular transport inhibitor, i.e., chloroquine (B). Calcium concentration in the apical and basolateral hemichambers was 1.25 mM. Nos. in parentheses represent the nos. of animals. **P Ͻ 0.01 and ***P Ͻ 0.001 vs. WT mice; ###P Ͻ 0.001 vs. calcium channels to prevent an excessive increase in cytoplasmic calcium concentration, a phenomenon known as calciumdependent inactivation (11) .
The duodenal transcellular calcium transport was actually very complex and exhibited highly redundant cellular mechanisms. Although TRPV5, TRPV6, and L-type calcium channel (e.g., Ca v 1.3) have been reported to be present in the apical membrane of the duodenal enterocytes (17, 21) , it was likely that only the L-type calcium channel contributed predominantly to the apical uptake in 1,25(OH) 2 D 3 -treated BKO mice.
This was supported by the fact that apical exposure to nifedipine or isradipine, both of which were L-type calcium channel blockers of the dihydropyridine class, completely abolished the 1,25(OH) 2 D 3 -induced transcellular calcium flux. Strikingly, the basolateral exposure to 5 M nifedipine also inhibited transcellular calcium transport. This led to a speculation that there must be vitamin D-dependent transcellular calcium transport mechanism, i.e., vesicular calcium transport that required the basolateral L-type calcium channel for exocytosis (31, 45) . A marked reduction in the 1,25(OH) 2 D 3 -induced transcellular calcium flux by chloroquine, which disrupted the function of acidified lysosome-like vesicle, thus corroborated the contribution of vesicular transport across the cytoplasm.
In addition to 1,25(OH) 2 D 3 , which is a potent stimulator of intestinal calcium absorption (46), we demonstrated that the negative regulator of iron absorption, hepcidin, also alleviated thalassemia-associated impairment of calcium transport. As mentioned earlier, it was hypothesized that iron hyperabsorption could be a factor that reduced calcium transport, as suggested previously by Wang et al. (44) and by the present inverse correlation between the duodenal calcium flux and iron flux (Fig. 4C) . Hence, hepcidin that markedly reduced the duodenal iron transport and serum iron level was expected to restore calcium transport. Meanwhile, the iron hyperabsorptive state in BKO mice did not affect the duodenal transport of zinc, another divalent ion.
It is not known exactly how iron reduces calcium absorption. Since Ca 2ϩ and Fe 2ϩ were transported by different channels/ transporters, i.e., TRPV6 and L-type calcium channel for Ca 2ϩ and DMT1 for Fe 2ϩ (12, 15, 28, 35) , iron might not compete with calcium for apical uptake. Similarly, the basolateral transporters were also different (i.e., NCX1 and PMCA 1b for calcium and FPN1 for iron). Nonetheless, both ions might share the same vesicular trafficking pathway (29, 32) , and it was tempting to speculate that excessive iron might occupy available vesicles inside the enterocytes. Alternatively, Fe 2ϩ and Ca 2ϩ might compete with each other to enter the vesicle since uptake mechanisms for both ions were dependent on proton gradient (acidic pH inside vesicle). We have learned from the experiments using inhibitors of NCX1, PMCA 1b , and the vesicular pathway that the disruption of only one of the three pathways could totally abolish transepithelial calcium transport. Therefore, it was possible that vesicular transport was the Values are means Ϯ SE; n ϭ 5. Female WT and BKO mice were injected with a single dose of hepcidin (100 g/kg sc) 4 h prior to measurement of electrical parameters. In some experiments, the duodenal epithelia were exposed directly to 200 nM recombinant hepcidin in an Ussing chamber. †Values are the magnitudes of PD, and the apical side is negative with reference to the basolateral side. site of iron-induced inhibition of calcium transport in BKO mice, although more investigation is required to confirm this postulation.
It was noteworthy that hepcidin did not affect the duodenal calcium transport in WT mice. However, in BKO mice, the hepcidin action occurred rapidly, i.e., within 30 min after direct exposure in an Ussing chamber. Both single-dose and 3-day injections of 100 g/kg hepcidin also positively affected the duodenal calcium transport, even though the calcium flux was determined at 4 h postinjection. Such a positive effect was not observed after 24 h. Since the half-life of hepcidin was indeed very short (within minutes) (13), hepcidin should alter certain enterocytic functions, presumably degradation of iron transporters (3) , that could continue for several hours (Ն4 h). Our time-dependent study of single-dose hepcidin action demonstrated that the hepcidin-induced decreases in DMT1 protein levels could prolong up to 72 h postinjection. This was eventually able to diminish cytoplasmic iron translocation by either carrier-mediated pathway or vesicular trafficking. The use of proteasome inhibitors (MG132 and bortezomib) confirmed the previous investigations reporting the hepcidin-induced proteasomal degradation of iron transporters (3). The subcellular mechanism(s) by which hepcidin degraded the duodenal iron transporters remained controversial and was probably species and tissue specific (10, 27, 33) . Specifically, it was previously hypothesized that hepcidin bound to the basolateral FPN1, leading to sequestration of FPN1 from the plasma membrane, followed by proteasomal degradation. However, in a recent mouse study, it was DMT1, not FPN1, that underwent hepcidin-induced proteasomal degradation (3), consistent with the present finding that showed no change in the level of FPN1 protein (Fig. 4D) . Our study in ␤ IVSII-654 knockin thalassemic mice showed that there was an increase in the mRNA level of DMT1, but not FPN1, in the duodenal mucosal cells (5), suggesting a greater contribution of DMT1 for iron hyperabsorption in ␤-thalassemia.
In conclusion, we have provided corroborative evidence that ␤-thalassemia could impair the paracellular and transcellular calcium transport, the latter of which was evidently associated with iron hyperabsorption. Both 1,25(OH) 2 D 3 and an antagonist of iron absorption, hepcidin, effectively rescued calcium transport in the duodenum of BKO mice. Therefore, our findings shed new light on the underlying mechanism of calcium derangement in ␤-thalassemia and provided a foundation for the development of calcium supplement strategy and a therapeutic approach for thalassemia-associated calcium malabsorption that might help alleviate thalassemic osteopenia and osteoporosis.
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